Lilly as an employment destination
Eli Lilly and Co. has experienced a string of setbacks in recent years. Is it still a good place to work?
Home » Search
Search Results
4,410 results for '\"eli lilly\"'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
UPDATE: Pipeline challenges force Lilly restructuring moves
Since John Lechleiter was named CEO 18 months ago, he’s bet that Eli Lilly and Co. could face down its looming patent challenges
by launching innovative new medicines. Today’s announcement of 5,500 job cuts by the end of 2011 and a restructuring of the
company’s business units ups the ante on that bet, while indicating that it isn’t working yet.Local health care industry tries to capitalize on migraine headaches
Migraines cost American employers $20 billion a year in decreased worker productivity. Such
a frequent and uncured disease stands as a huge business opportunity for the health care industry, including locally based pharmaceutical giant Eli Lilly and Co.Lilly revises playbook in effort to score more ‘touchdowns’
The drugmaker has successfully moved experimental drugs into position to win approval by regulators. But only once in the
last four years has a new drug actually made it to market—the industry’s equivalent of getting
across the goal line.Lilly: Alimta improves lung-cancer survival time
Indianapolis-based Eli Lilly and Co. announced today that a clinical trial showed lung cancer patients treated with Lilly
drug Alimta lived about three months longer than those who received the best available care.Lilly: Alimta improves survival in lung cancer
Indianapolis-based Eli Lilly and Co. announced today that a clinical trial showed lung cancer patients treated with Lilly
drug Alimta lived about three months longer than those who received the best available care. Alimta is used as a “maintenance
therapy” for patients whose disease has not progressed after chemotherapy. In a study involving 663 patients, Lilly said patients
treated with Alimta and best available care lived for an average of 13.4 months. Those treated with best care and a placebo
lived for an average of 10.6 months.Lilly sells constipation drug to Adolor
Biotechnology company Adolor Corp. said yesterday that it bought exclusive worldwide rights to Eli Lilly and Co.’s OpRA
III drug candidate, which has a range of potential uses.Lilly agrees to settle more state Zyprexa suits
Eli Lilly and Co. has agreed to confidential terms to settle lawsuits brought by seven states alleging the company illegally
marketed bestselling antipsychotic drug Zyprexa, Bloomberg News reported today.Bartering booms during recession
In a recession, cash is a commodity few small businesses can spare. That’s why more businesses are trading goods and services without exchanging cash.
Judge upholds Lilly’s Evista patent
A federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.’s drug Evista, the company announced
late yesterday.Lilly’s win in Evista patent case crucial, analyst says
A decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.’s Evista marks a major
victory for the company, says an analyst who closely follows the pharmaceutical industry.Local Better Business Bureau names new leader
William J. Thomas has been named president of the Better Business Bureau of Central Indiana, the organization announced Monday.
Connecticut gets $25 million from Zyprexa lawsuit
Connecticut officials say Eli Lilly and Co. has agreed to a $25 million settlement with the state over claims the drug maker
marketed its anti-psychotic drug, Zyprexa, for unapproved uses and harmed patients.Overhaul of teacher training threatens college budgets
Proposed changes to teacher licensing rules are a threat in the eyes of most deans of Indiana’s colleges of education—both
to the quality
of
teacher training and to the budgets of the colleges.IT consultant up for tax abatement
A city board this week will consider tax abatements worth about $47,000 over six years for Indianapolis-based IT consultant
Apparatus Inc., which is moving its headquarters to the former WFYI building at 1401 N. Meridian St.Senate bill doesn’t fund Rolls-Royce jet engine
The measure holds potential bad news for Indianapolis engine maker Rolls-Royce because it does not contain funding for a key
jet engine the company produces, but lawmakers are expected to restore funding when the Senate and House combine bills into
a final version.Lilly settles Zyprexa suit with S. Carolina
Eli Lilly and Co. has agreed to settle the State of South Carolina’s lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.ROOB: Math proficiency a must for work force
The recent slump in the domestic auto industry reminds us of the importance of innovation and creating something that will
be attractive to the consumer tomorrow. Companies that don’t foresee and adapt to the changing needs of their consumers
ultimately fail.House OKs defense bill that funds Rolls Royce engine
Despite a vaguely worded veto threat by President Barack Obama, the House on Thursday easily adopted a major defense
policy bill that calls for continued development of a costly alternative engine for the Pentagon’s next-generation fighter
jet.Baucus health reform bill would stick Indiana companies with fees
The health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.